Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses

Diabetes

Volumn 54, Issue 4, 2005, Pages 1048-1055

  Mirenda, Vicenzo ^a   Golshayan, Dela ^a   Read, Joseph ^a   Berton, Ivan ^a   Warrens, Anthony N ^a   Dorling, Anthony ^a   Lechler, Robert I ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ALCOHOL; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; IMMUNOGLOBULIN; OXAZOLONE;

ADOPTIVE TRANSFER; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTACT SENSITIVITY; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; IMMUNOCOMPETENCE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; XENOGRAFT;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; GENES, MHC CLASS II; GRAFT REJECTION; IMMUNOCONJUGATES; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; SWINE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 15944424560     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.4.1048     Document Type: Article

References (37)

1. Platt JL, Lindman BJ, Geller RL, Noreen HJ, Swanson JL, Dalmasso AP, Bach FH: The role of natural antibodies in the activation of xenogeneic endothelial cells. Transplantation 52:1037-1043, 1991
2. Leventhal JH, Matas AJ, Sun LH: The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation 56:1-8, 1993
3. Galili U: Interaction of the natural ant-Gal antibody with alpha-galactosil epitope: a major obstacle for xenotransplantation in humans. Immunol Today 14:480-482, 1993
4. Contreras JL, Eckhoff DE, Cartner S, Bilbao G, Ricordi C, Neville DM Jr, Thomas FT, Thomas JM: Long-term functional islet mass and metabolic function after xenoislet transplantation in primates. Transplantation 69:195-201, 2000
5. Smith RM, Mandel TE: Pancreatic islet xenotransplantation: the potential for tolerance induction. Immunol Today 21:42-48, 2000
6. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, Andersson A: Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402-1404, 1994
7. Mirenda V, Le Mauff B, Cassard A, Huvelin JM, Boeffard F, Faivre A, Soulillou JP, Anegon I: Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation. Transplantation 63:1452-1462, 1997
8. Mirenda V, Le Mauff B, Boeffard F, Cassard A, Jugeau N, Soulillou JP, Anegon I: Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination. Transplantation 66:1485-1495, 1998
9. Dorling A, Lombardi G, Binus R, Lechler RI: Detection of primary direct and indirect human anti-porcine T-cell responses using a porcine dendritic cell population. Eur J Immunol 26:1378-1387, 1996
10. Dorling A, Binus R, Lechler RI: Cellular xenoresponses: observation of significant primary indirect human T-cell anti-pig xenoresponses using costimulator-deficient or SLA class-II negative porcine stimulators. Xenotransplantation 3:112-119, 1996
11. Yamada K, Sachs DH, DerSimonian H: Human anti-porcine xenogeneic T-cell response: evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 155:5249-5253, 1995
12. Kirk AD, Li RA, Kinch MS, Abernethy KA, Doyle C, Bollinger RR: The human anti-porcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 55:924-931, 1993
13. Maher SE, Karmann K, Min W, Hughes CC, Pober JS, Bothwell AL: Porcine endothelial CD86 is a major costimulator of xenogeneic human T-cells: cloning, sequencing, and functional expression in human endothelial cells. J Immunol 157:3838-3844, 1996
14. Lee RS, Yamada K, Womer KL, Pillsbury EP, Allison KS, Marolewski AE, Geng D, Thall AD, Arn JS, Sachs DH, Sayegh MH, Madsen JC: Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogenic porcine and xenogeneic human anti-porcine T-cell responses. J Immunol 164: 3434-3444, 2000
15. Lehnert AM, Yi S, Burgess JS, O'Connell PJ: Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T-cell apoptosis but not immune deviation. Transplantation 69:1176-1185, 2000
16. Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA: The role of CD80, CD86, and CTLA4 in alloimmune responses and in the induction of long-term allograft survival. J Immunol 162:1947-1951, 1999
17. Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, Linsley PS, Bluestone JA: Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4-Ig. Science 257:789-792, 1992
18. Vaughan AN, Malde P, Rogers NJ, Jackson IM, Lechler RI, Dorling A: Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T-cell responses costimulated by pig but not human B7. J Immunol 165:3175-3181, 2000
19. Rogers NJ, Mirenda V, Jackson I, Dorling A, Lechler RI: Costimulatory blockade by the induction of an endogenous xenospecific antibody response. Nat Immunol 1:163-168, 2000
20. Rogers NJ, Jackson IM, Jordan WJ, Hawadle MA, Dorling A, Lechler RI: Cross-species costimulation: relative contributions of CD80, CD86, and CD40. Transplantation 75:2068-2076, 2003
21. Gilbert MA, Charreau B, Vicart P, Paulin D, Nandi PK: Mechanism of entry of a xenotropic MMuLV-derived recombinant retrovirus into porcine cells using the expression of the reporter nlslacZ gene. Arch Virol 124:57-67, 1992
22. Dorling A, Monk NJ, Lechler RI: HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 30:586-593, 2000
23. Dorling A, Binns R, Lechler RI: Cellular xenoresponses: although vigorous, direct human T-cell anti-pig primary xenoresponses are significantly weaker than equivalent alloresponses. Xenotransplantation 3:149-157, 1996
24. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702, 1992
25. Lacy PE, Davie JM, Finke EH: Prolongation of islet xenograft without continuous immunosuppression. Science 209:283-285, 1980
26. Lacy PE, Davie JM, Finke EH: Prolongation of islet allograft survival following in vitro culture (24°C) and a single injection of ALS. Science 204:312-313, 1979
27. Faustman DL, Steinman RM, Gebel HM, Hauptfeld V, Davie JM, Lacy PE: Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A 81:3864-3868, 1984
28. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Blanchi R, Fioretti MC, Puccetti P: CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3:1097-1101, 2002
29. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM: Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 172:1483-1493, 1990
30. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C: Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833-2838, 1990
31. Lechler RI, Batchelor JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155:31-41, 1982
32. Dorling A, Lechler RI: T-cell-mediated xenograft rejection: specific tolerance is probably required for long term xenograft survival. Xenotransplantation 5:234-245, 1998
33. Rivereau AS, You S, Lalain S, Gouin E, Sai P: In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice. Transplantation 66:633-638, 1998
34. Faustman D, Hauptfeld V, Lacy P, Davie J: Prolongation of murine islet allograft survival by pre-treatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci USA 78:5156-5159, 1981
35. Wolf LA, Coulombe M, Gill RG: Donor antigen-presenting cell-independent rejection of islet xenografts. Transplantation 60:1164-1170, 1995
36. Rayat GR, Johnson ZA, Beilke JN, Korbutt GS, Rajotte RV, Gill RG: The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes 52:1433-1440, 2003
37. Baker RJ, Hernandez-Fuentes M, Brookes PA, Chaudnry AN, Cook HT, Lechler RI: Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 167:7199-7206, 2001